122 related articles for article (PubMed ID: 10876739)
1. Linezolid approval brings new treatment option for resistant bacteria.
Am J Health Syst Pharm; 2000 Jun; 57(11):1018. PubMed ID: 10876739
[No Abstract] [Full Text] [Related]
2. A novel antimicrobial agent joins the battle against resistant bacteria.
Moellering RC
Ann Intern Med; 1999 Jan; 130(2):155-7. PubMed ID: 10068364
[No Abstract] [Full Text] [Related]
3. In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to the novel oxazolidinones eperezolid (PNU-100592) and linezolid (PNU-100766).
Hoppe JE
J Chemother; 1999 Jun; 11(3):220-1. PubMed ID: 10435686
[No Abstract] [Full Text] [Related]
4. New antibiotics for gram positive infections: linezolid and combination quinapristin/dalfopristin.
MacConnachie AM
Intensive Crit Care Nurs; 1999 Aug; 15(4):239-41. PubMed ID: 10786510
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of persistent vancomycin-resistant Enterococcus faecium bacteremia with linezolid and gentamicin.
Noskin GA; Siddiqui F; Stosor V; Kruzynski J; Peterson LR
Clin Infect Dis; 1999 Mar; 28(3):689-90. PubMed ID: 10194104
[No Abstract] [Full Text] [Related]
6. Linezolid breakpoints.
European Committee on Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID)
Clin Microbiol Infect; 2001 May; 7(5):283-4. PubMed ID: 11422259
[No Abstract] [Full Text] [Related]
7. An update on the oxazolidinone antibiotics.
Abdel-Rahman SM; Kearns GL
Pediatr Infect Dis J; 1999 Dec; 18(12):1101-2. PubMed ID: 10608633
[No Abstract] [Full Text] [Related]
8. Use of linezolid, an oxazolidinone, in the treatment of multidrug-resistant gram-positive bacterial infections.
Chien JW; Kucia ML; Salata RA
Clin Infect Dis; 2000 Jan; 30(1):146-51. PubMed ID: 10619743
[TBL] [Abstract][Full Text] [Related]
9. Methicillin-resistant Staphylococcus aureus infection in a renal allograft recipient treated successfully with a novel new antimicrobial agent (linezolid): new treatment options for infections due to resistant organisms.
Antony SJ; Bitter KM; Moreland T; Raudales F; Diaz-Luna H
Clin Infect Dis; 1999 Nov; 29(5):1341-2. PubMed ID: 10524997
[No Abstract] [Full Text] [Related]
10. The pharmacologic and bacteriologic properties of oxazolidinones, a new class of synthetic antimicrobials.
Dresser LD; Rybak MJ
Pharmacotherapy; 1998; 18(3):456-62. PubMed ID: 9620097
[TBL] [Abstract][Full Text] [Related]
11. Preface. The evidence for the clinical role of linezolid beyond its licence.
Koerner R; Hope R
J Antimicrob Chemother; 2011 May; 66 Suppl 4():iv1. PubMed ID: 21553405
[No Abstract] [Full Text] [Related]
12. [Linezolid (Zyvox)--a novel antibacterial agent for treatments of multidrug-resistant infections].
Blatun LA
Antibiot Khimioter; 2002; 47(2):38-46. PubMed ID: 12087723
[No Abstract] [Full Text] [Related]
13. Linezolid.
Clemett D; Markham A
Drugs; 2000 Apr; 59(4):815-27; discussion 828. PubMed ID: 10804037
[TBL] [Abstract][Full Text] [Related]
14. New drugs for osteoarthritis and infections caused by gram-positive bacteria.
Home Healthc Nurse; 2000; 18(10):632. PubMed ID: 11951731
[No Abstract] [Full Text] [Related]
15. Potential serious adverse interactions between linezolid and atomoxetine.
Aggarwal A; Kulkarni G; Jahan S
J Child Adolesc Psychopharmacol; 2012 Oct; 22(5):405. PubMed ID: 23083031
[No Abstract] [Full Text] [Related]
16. [A new antibacterial agent can stop resistance development. Expectations are connected to linezolid, an oxazolidinone with a new pharmacological action].
Sköld O
Lakartidningen; 1999 Sep; 96(37):3866-7. PubMed ID: 10522087
[No Abstract] [Full Text] [Related]
17. Have the oxazolidinones lived up to their billing? Future perspectives for this antibacterial class.
Nilius AM
Curr Opin Investig Drugs; 2003 Feb; 4(2):149-55. PubMed ID: 12669374
[TBL] [Abstract][Full Text] [Related]
18. [Oxazolidinones. A new anti-infective principle].
Roloff T; Holtfoht A; Ziegler A; Heinzl S
Med Monatsschr Pharm; 1999 Dec; 22(12):370-5. PubMed ID: 10628146
[No Abstract] [Full Text] [Related]
19. Linezolid Pharmacia Corp.
Barrett JF
Curr Opin Investig Drugs; 2000 Oct; 1(2):181-7. PubMed ID: 11249571
[TBL] [Abstract][Full Text] [Related]
20. Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid.
Gonzales RD; Schreckenberger PC; Graham MB; Kelkar S; DenBesten K; Quinn JP
Lancet; 2001 Apr; 357(9263):1179. PubMed ID: 11323048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
